Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2025-12-25 @ 10:05 PM
Study NCT ID:
NCT04431258
Status:
COMPLETED
Last Update Posted:
2024-03-18
First Post:
2020-05-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study
Sponsor:
Ability Pharmaceuticals SL
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-27
First Submit QC Date:
None
Study First Post Date:
2020-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-15
Last Update Post Date:
2024-03-18
Last Update Post Date Type:
ACTUAL